Why should We Bother? Ethical and Social Issues in Individualized Medicine

By  

Current Drug Targets, Vol. 7, Iss. 12, 2006-01 ,pp. : 1721-1727

Bentham Science Publishers

Access to resources Recommend Favorite

Current Evidence from Phase III Clinical Trials of Selenium Supplementation in Critically Ill Patients: Why Should We Bother?

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 7, 2007-07 ,pp. : 693-699

Bentham Science Publishers

Access to resources Recommend Favorite

Should we implement ‘opt-out’ HIV testing for patients with lymphoma?

By Cave J   Edwards SG   Miller RF   Ardeshna KM   Lee SM  

Clinical Medicine, Vol. 9, Iss. 4, 2009-08 ,pp. : 320-322

Royal College Of Physicians

Access to resources Recommend Favorite

Can HIV epidemics among IDUs 'trigger' a generalised epidemic?

By Wiessing L.   Kretzschmar M.  

The International Journal of Drug Policy, Vol. 14, Iss. 1, 2003-02 ,pp. : 99-102

Elsevier

Access to resources Recommend Favorite

Characteristics of High-Risk HIV-Positive IDUs in Vietnam: Implications for Future Interventions

By Go Vivian F.   Frangakis Constantine   Nam Le Van   Sripaipan Teerada   Bergenstrom Anna   Li Fan   Latkin Carl   Celentano David D.   Quan Vu Minh  

Substance Use & Misuse, Vol. 46, Iss. 4, 2011-02 ,pp. : 381-389

Informa Healthcare

Access to resources Recommend Favorite